Santen Pharmaceutical Director of Finance Salaries in San Francisco | Comparably
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
132

Santen Pharmaceutical Director of Finance Salaries in San Francisco

The average Santen Pharmaceutical Director of Finance in San Francisco earns an estimated $167,261 annually. Santen Pharmaceutical's Director of Finance compensation is $5,246 more than the US average for a Director of Finance.

In San Francisco, The Finance Department at Santen Pharmaceutical earns $7,654 more on average than the Customer Support Department.

Last updated 4 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$167,261
Average Compensation
$167,261
avg. base

Director of Finance Salaries at Santen Pharmaceutical

In San Francisco, Directors of Finance earn $23,045 more than Accounting Managers.

Accounting Manager
$144k*
Financial Analyst
$107k*
Senior Accountant
$103k*
Business Analyst
$100k*
Accountant
$83k*
* estimated salary

Compensation at Santen Pharmaceutical by Department

In San Francisco, The Finance Department averages $7,654 more than the Customer Support Department, and $10,164 less than the Marketing Department

Marketing
$107,698 Avg. total comp.
+$10k
Finance
$97,534 Avg. total comp.
Customer Support
$89,880 Avg. total comp.
-$8k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Santen Pharmaceutical reported making $169,182, while the average male Director of Finance at similar sized companies reported making $188,100.

Director of Finance Compensation by Ethnicity (All Companies)

The average Caucasian Director of Finance at companies similar size to Santen Pharmaceutical reported making $184,183, while the average Native American Director of Finance at similar sized companies reported making $30,000.

How Directors of Finance at Santen Pharmaceutical Rate Their Compensation

The majority of Directors of Finance at Santen Pharmaceutical believe they're not compensated fairly. 50% of Directors of Finance at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical

×
Rate your company